Possible new drug targets for the genetic disorder Noonan syndrome

Noonan syndrome is a relatively common genetic disorder characterized by short stature, unique facial features, and heart defects. About 10-15 percent of affected individuals have mutations in their SOS1 gene. Researchers have now generated mice expressing a Sos1 mutation associated with Noonan syndrome and used them to identify potential therapeutic targets for the treatment of this condition.

Read the whole article on Science Daily

More from Science Daily